Constantly Bombarded with New Drugs: What’s a Cardiologist to Do?
By: Albert E. Raizner and James B. Young
References
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/AHSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063
- Zinman B, Wanner C, Lachin JM, et al. Empagliflozin. Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015 Nov 26;373:2117-2128. doi: 10.1056/NEJMoa1504720
DOI: https://doi.org/10.14797/mdcvj.1179 | Journal eISSN: 1947-6108
Language: English
Page range: 74 - 76
Submitted on: Oct 31, 2022
Accepted on: Nov 1, 2022
Published on: Dec 6, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 Albert E. Raizner, James B. Young, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.